VBVladyslav Berezovskyi

Vladyslav Berezovskyi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vladyslav Berezovskyi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Open Field Test Video Recordings in Mice Exposed to Traumatic Stress and Glycine Treatment

    by Olha Strilbytska, Viktoria Hurza, Vladyslav Berezovskyi, Myroslava Vatashchuk, Vitalii Derkachov, Maria Lylyk

    This dataset contains original, unprocessed video recordings of the Open Field Test (OFT) performed in male C57BL/6J mice aged 4 months. The dataset includes recordings from control, stress-exposed animals and stress-exposed animals treated with glycine. The videos are provided as raw recordings to allow independent behavioral analysis using manual scoring or automated video-tracking methods. Researchers may use the dataset to develop, test, and validate methods for behavioral tracking and quantification, as well as to compare analytical approaches for assessing mouse behavior in the Open Field Test. The accompanying metadata describe the experimental groups and relevant characteristics of the animals and video recordings.

  • Open Access

    Behavioral and Molecular Effects of Magnesium and Vitamin B6 Complex in a Mouse Model of Post-Traumatic Stress Disorder

    by Olha Strilbytska, Viktoria Hurza, Myroslava Vatashchuk, Vitalii Derkachov, Vladyslav Berezovskyi, Oleh Demianchuk, Oleh Lushchak, Maria Lylyk, Maria Bayliak

    Exposure to severe or uncontrollable traumatic stress factors often results in long-lasting alterations in emotional regulation and memory, leading to development of symptoms of post-traumatic stress disorder (PTSD). The present study evaluated the behavioral and neurobiochemical effects of a magnesium-vitamin B6 complex in a mouse PTSD model of PTSD induced by inescapable electric foot-shock. Male C57BL/6J mice were randomly divided into three groups: Control, Stress (exposure to electric foot shock), and Stress+Mg-B6 (electric foot shock with poststress administration of Mg-B6 complex with increasing dose from 100 to 200 mg/kg body mass). To assess the development of PTST-like symptoms, a battery of behavioral tests was used, including the aversive context test, open field test, light-dark box, elevated plus maze, splash test, and tail suspension test. Mice exposed to electric shocks demonstrated markedly longer freezing times compared with controls, indicating enhanced fear memory. Treatment with Stress+Mg-B6 resulted in reduced locomotor activity and shorter time spent in open areas in both the open field and elevated plus maze, suggesting transient behavioral inhibition. The Mg-B6 complex also reduced grooming behavior in splash test, which may indicate a lower motivational drive or suppression of stress-induced arousal rather than depressive-like symptoms. Electrical shock caused a decrease in total leukocyte levels but an increase in plasma myeloperoxidase activity. These changes were not modulated by the Mg-B6 complex. No significant changes in paraoxonase activity, IL-1β levels in blood, or cortex lipid peroxide levels were found in any of the experimental groups. Overall, the study suggests that high doses of Mg-B6 can modulate stress-related neurobehavioral responses, which appear to transiently suppress exploratory and motivational behaviors, possibly due to the inhibitory action of magnesium on neuronal excitability.

  • Open Access

    Behavioral Effects of Magnesium and Vitamin B6 Complex in a Mouse Model of Post-Traumatic Stress Disorder

    by Olha Strilbytska, Viktoria Hurza, Myroslava Vatashchuk, Vitaliy Derkachov, Vladyslav Berezovskyi, Maria Lylyk, Maria Bayliak

    Exposure to severe or uncontrollable stress often results in long-lasting alterations in emotional regulation and memory, resembling symptoms of post-traumatic stress disorder (PTSD). The present study evaluated the behavioral effects of a magnesium-vitamin B6 complex in a mouse model of PTSD-like stress induced by inescapable electric foot-shock. Male C57BL/6J mice were randomly divided into Control, Stress, and Stress+Mg-B6 groups. Elevated Plus Maze was used to evaluate anxiety level in experimental mice. Treatment with Mg-B6 complex resulted in reduced locomotor activity and shorter time spent in open arms of the elevated plus maze, suggesting transient behavioral inhibition. The results indicate lowered motivational drive or adaptive suppression of stress-induced arousal. The compound appears to transiently suppress exploratory and motivational behaviors, possibly due to the inhibitory action of magnesium on neuronal excitability.

  • Open Access

    Effects of Rhodiola rosea and aspirin on behaviour and some biochemical parameters in old mice

    by Vitalii Derkachov, Vladyslav Berezovskyi

    This study investigates the effects of aqueous Rhodiola rosea extract and low-dose and high-dose aspirin on behaviour and biochemical parameters in aged C57BL/6J mice. Both substances are widely recognized for their therapeutic properties and potential geroprotective effects in simpler organisms such as yeast and Drosophila. Aspirin, or acetylsalicylic acid, is a medication used for the treatment of pain and fever and also possesses anti-inflammatory and antipyretic properties. It is found to prolong lifespan of model organisms if taken throughout life but not in the old age. R. rosea is considered a geroprotector with rejuvenating properties. It contains a variety of compounds that may act as anti-inflammatory or anti-cancer agents. Additionally, evidence suggests that R. rosea extracts improve quality of life in the elderly and extend lifespan. Mice aged 17 months (comparable to approximately 80 human years) were administered R. rosea extract or aspirin (5 mg/kg and 25 mg/kg body mass daily) for two months. Behavioural assessment using the open field test revealed no significant differences between the groups, although trends suggested increased anxiety-like behaviour in mice receiving 25 mg aspirin. Biochemical analysis showed no statistically significant changes in lipid peroxidation in the brain or liver enzyme activities (alanine aminotransferase, ALT, and aspartate aminotransferase, AST), although a trend toward elevated ALT activity with aspirin supplementation was observed, indicating potential liver stress. These findings highlight the complexity of assessing geroprotective interventions in aged organisms and suggest that both R. rosea extract and aspirin, at the tested doses, may have limited efficacy in improving healthspan in older mice. Further studies with larger cohorts and additional biomarkers are needed to explore these preliminary findings.


  • Open Access

    Metabolic and immune dysfunctions in post-traumatic stress disorder

    by Oleh Lushchak, Marco Orru, Olha Strilbytska, Vladyslav Berezovskyi, Andriy Cherkas, Kenneth B. Storey, Maria Bayliak

    Highly stressful experiences such as terrorist attacks, domestic and sexual violence may lead to persistent pathological symptoms such as those seen in posttraumatic stress disorder (PTSD). There is growing evidence of multiple metabolic and immune disorders underlying the etiology and maintenance of PTSD. However, changes in the functioning of various systems and organs associated with PTSD are not well understood. Studies of reliable animal models is one of the effective scientific tools that can be used to gain insight into the role of metabolism and immunity in the comorbidity associated with PTSD. Since much progress has been made using animal models to understand mechanisms of PTSD, we summarized metabolic and immune dysfunction in mice and humans to compare certain outcomes associated with PTSD. The systemic effects of PTSD include chronic activation of the sympathetic nervous system (psycho-emotional stress), that leads to impairment of the function of the immune system, increased release of stress hormones, and metabolic changes. We discuss PTSD as a multisystem disease with its neurological, immunological, and metabolic components.